Cargando…
Anti-amyloid aggregation activity of novel carotenoids: implications for Alzheimer’s drug discovery
Alzheimer’s disease (AD) is the leading cause of dementia, affecting approximately 33.5 million people worldwide. Aging is the main risk factor associated with AD. Drug discovery based on nutraceutical molecules for prevention and treatment of AD is a growing topic. In this sense, carotenoids are ph...
Autores principales: | Lakey-Beitia, Johant, Doens, Deborah, Jagadeesh Kumar, D, Murillo, Enrique, Fernandez, Patricia L, Rao, KS, Durant-Archibold, Armando A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440000/ https://www.ncbi.nlm.nih.gov/pubmed/28553090 http://dx.doi.org/10.2147/CIA.S134605 |
Ejemplares similares
-
Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis
por: Lakey-Beitia, Johant, et al.
Publicado: (2019) -
Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis
por: Doens, Deborah, et al.
Publicado: (2014) -
β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19
por: Ikewaki, Nobunao, et al.
Publicado: (2021) -
Polyphenols with Anti-Inflammatory Properties: Synthesis and Biological Activity of Novel Curcumin Derivatives
por: González, Yisett, et al.
Publicado: (2023) -
Palladium-Catalyzed C8-Selective C–H Arylation
of Quinoline N-Oxides: Insights into the Electronic,
Steric, and Solvation Effects on the Site Selectivity by Mechanistic
and DFT Computational Studies
por: Stephens, David E., et al.
Publicado: (2014)